Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
65.43 -0.74    -1.12%
01:27:39 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 2,011,301
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 65.21 - 66.43
Gilead 65.43 -0.74 -1.12%

GILD Balance Sheet

 
Featured here, the Balance Sheet for Gilead Sciences Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 12750 16085 15980 14287
Cash and Short Term Investments 4718 8350 7974 7098
Cash - - - -
Cash & Equivalents 4718 6085 5705 5704
Short Term Investments - 2265 2269 1394
Total Receivables, Net 4669 4660 4790 4229
Accounts Receivables - Trade, Net 4669 4660 4790 4229
Total Inventory 3363 1787 1663 1633
Prepaid Expenses - 1281 1495 1302
Other Current Assets, Total - 7 58 25
Total Assets 56292 62125 62373 62337
Property/Plant/Equipment, Total - Net 5321 5898 5572 5540
Property/Plant/Equipment, Total - Gross - 8347 - -
Accumulated Depreciation, Total - -2449 - -
Goodwill, Net 8314 8314 8314 8314
Intangibles, Net 23428 26454 27152 27750
Long Term Investments - 2159 1737 2746
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 6479 3215 3618 3700
Other Assets, Total -1306 -601 -800 -1177
Total Current Liabilities 13015 11280 11945 13964
Accounts Payable - 550 586 622
Payable/Accrued - - - -
Accrued Expenses - 5003 4675 4258
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - 1923 1793 4037
Other Current liabilities, Total 13015 3804 4891 5047
Total Liabilities 38837 39376 40131 41243
Total Long Term Debt 25822 23189 23189 21209
Long Term Debt 25822 23189 23189 21209
Capital Lease Obligations - - - -
Deferred Income Tax - 1588 1984 2106
Minority Interest - -84 -72 -64
Other Liabilities, Total - 3403 3085 4028
Total Equity 17455 22749 22242 21094
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 17455 1 1 1
Additional Paid-In Capital - 6500 6279 6008
Retained Earnings (Accumulated Deficit) - 16304 16002 15138
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -56 -40 -53
Total Liabilities & Shareholders' Equity 56292 62125 62373 62337
Total Common Shares Outstanding 1246 1246 1247 1247
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email